Cell‐by‐cell quantification of the androgen receptor in benign and malignant prostate leads to a better understanding of changes linked to cancer initiation and progression

por Derderian, Seta, Benidir, Tarik, Scarlata, Eleonora, Altaylouni, Turki, Hamel, Lucie, Zouanat, Fatima Zahra, Brimo, Fadi, Aprikian, Armen, Chevalier, Simone
Publicado 2023

Liquid biopsy‐based targeted gene screening highlights tumor cell subtypes in patients with advanced prostate cancer

por Derderian, Seta, Vesval, Quentin, Wissing, Michel D., Hamel, Lucie, Côté, Nathalie, Vanhuyse, Marie, Ferrario, Cristiano, Bladou, Franck, Aprikian, Armen, Chevalier, Simone
Publicado 2022

Improving ultrasound-based prostate volume estimation

por Aprikian, Saro, Luz, Murilo, Brimo, Fadi, Scarlata, Eleonora, Hamel, Lucie, Cury, Fabio L., Tanguay, Simon, Aprikian, Armen G., Kassouf, Wassim, Chevalier, Simone
Publicado 2019

Asporin is a stromally expressed marker associated with prostate cancer progression

por Rochette, Annie, Boufaied, Nadia, Scarlata, Eleonora, Hamel, Lucie, Brimo, Fadi, Whitaker, Hayley C, Ramos-Montoya, Antonio, Neal, David E, Dragomir, Alice, Aprikian, Armen, Chevalier, Simone, Thomson, Axel A
Publicado 2017

Nuclear mTOR acts as a transcriptional integrator of the androgen signaling pathway in prostate cancer

por Audet-Walsh, Étienne, Dufour, Catherine R., Yee, Tracey, Zouanat, Fatima Z., Yan, Ming, Kalloghlian, Georges, Vernier, Mathieu, Caron, Maxime, Bourque, Guillaume, Scarlata, Eleonora, Hamel, Lucie, Brimo, Fadi, Aprikian, Armen G., Lapointe, Jacques, Chevalier, Simone, Giguère, Vincent
Publicado 2017